Brambles Limited denies misleading shareholders

Brambles Limited (ASX:BXB) has denied misleading and deceiving investors as the company prepares to face a class action suit.

a woman

Supply-chain logistics company Brambles Limited (ASX: BXB) has stated that is will defend allegations of misleading and deceiving shareholders in relation to its FY17 guidance.

Brambles shareholders, represented by law firm Slater & Gordon Limited (ASX: SGH) and supported by litigation funder IMF Bentham Ltd (ASX: IMF), claim that Brambles knowingly provided the market with false information when Brambles released its FY16 results and provided guidance for its FY17 financial performance on 18 August 2016.

Brambles reiterated its FY17 guidance at its first quarter trading update in October 2016 and again in November 2016 at its AGM, according to a statement released by IMF Bentham.

But Brambles changed its tune soon after.

"In a series of announcements released to the ASX on 23 January 2017 and 20 February 2017, Brambles withdrew the FY17 Guidance," IMF Bentham stated.

"The market responded with falls in Brambles' share price of 15.8% and 10% on 23 January and 20 February 2017, respectively."

Prior to the falls, Brambles shares were trading for up to $12.62 in mid-January but had tumbled to about $9.04 by mid-March.

Brambles shares are currently trading for around $9.78, still well short of the highs shareholders enjoyed at the start of 2017.

"It will be alleged that Brambles ultimately attributed the FY17 Downgrade to factors which it was, or should have been, aware of at the time it issued the FY17 Guidance in August 2016, which were not disclosed to the market at that time or at any time until later in 2017," IMF Bentham stated.

The proceedings apply to shareholders who acquired an interest in Brambles between 18 August 2016 and 17 February 2017.

Brambles has denied the allegations.

"Brambles strongly believes that it has at all times complied with its continuous disclosure, Corporations Act and other regulatory obligations and will therefore vigorously defend the proceedings brought against it," the company stated.

Motley Fool contributor Steve Holland has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Man sitting in a plane seat works on his laptop.
Broker Notes

Qantas shares were just downgraded but I still rate them as a buy

I think the downgrade was wrong and see value in the airline's shares.

Read more »

Smiling miner.
Broker Notes

4 ASX mining shares with 90% to 155% upside ahead: experts

These ASX mining shares have outstanding price growth potential.

Read more »

A woman smiles at the outlook she sees through binoculars.
Broker Notes

3 ASX shares tipped by brokers to return 48% to 109% over the next 12 months

Find out which ASX share is forecast to climb the highest by this time next year.

Read more »

a water tap is turned on and showering out banknotes into the open hand of a woman below it.
Broker Notes

This ASX small cap could jump 262% over the next year, one analyst says

This water technology company is having a strong year.

Read more »

Happy woman holding an umbrella while spreading her arms out in the rain.
52-Week Highs

IAG share price hits fresh 52-week high: Is there any upside left?

The shares last passed the $9-mark in June last year.

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face.
Broker Notes

Woolworths, NextDC, Telstra shares: Buy, sell, or hold?

Here’s what the experts tip for these three major ASX shares.

Read more »

Man and woman sitting at table with the man looking a bit puzzled at his laptop.
Broker Notes

Buy, hold, sell: Wisetech Global, Wesfarmers, CSL shares

Christopher Watt from Bell Potter explains his ratings on 3 ASX 200 sector heavyweights.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Broker Notes

3 buy-rated biotechnology companies, including one which could jump 400%

If you're looking for exposure to healthcare, these companies could be worth a look.

Read more »